Marshall Wace’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Marshall Wace’s Portfolio RYZB Stock Details RYZB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-58,800	Closed	-$3.66M	–	2918
2023 Q4	$3.66M	Sell	58,800 -293,178	-83%	-$7.29M	0.01%	1020
2023 Q3	$7.81M	Buy	+351,978	New	+$7.39M	0.02%	726

Marshall Wace's RYZB Position: Q1 2024 in Review

Marshall Wace sold out of RayzeBio, Inc. Common Stock (RYZB) in Q1 2024, closing a stake of 58,800 shares — an estimated $3.66M sold.

Marshall Wace first reported a position in RYZB in Q3 2023 and held it in 2 quarters. The position peaked at $7.81M in Q3 2023. 0 funds tracked by Wall St. Rank hold RYZB as of Q1 2024.

Marshall Wace reported no remaining RayzeBio, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Marshall Wace sold 58,800 RayzeBio, Inc. Common Stock shares in Q1 2024, an estimated $3.66M.
Marshall Wace first reported a position in RayzeBio, Inc. Common Stock in Q3 2023 and held it in 2 quarters.
Marshall Wace's RayzeBio, Inc. Common Stock position peaked at $7.81M in Q3 2023.
0 funds tracked by Wall St. Rank held RayzeBio, Inc. Common Stock as of Q1 2024.

Based on Marshall Wace's 13F filing for Q1 2024, filed 15 May 2024.